Our expertise

Professor Derk-Jan Dijk BSc, MSc, PhD – Director of Sleep/Wake Research, Professor of Sleep and Physiology and Director of the Surrey Sleep Research Centre (SSRC)

Prof Dijk has more than 25 years of experience in sleep research. His research interests include the evaluation of human sleep and biological rhythms, quantitative EEG analysis, effects of light on sleep, performance and circadian rhythms, aging and sleep disorders.

He has worked collaboratively with the Pharmaceutical Industry on a number of projects involving the development of hypnotics and counter measures for shift-work and jet lag. His research is also funded by the Biotechnology and Biological Sciences Research Council and The Airforce Office of Scientific Research.

Professor Dijk is a Member of the European Sleep Research Society, Sleep Research Society, British Sleep Society, The Society for Neuroscience and the Society for Research on Biological Rhythms. He has published more than 150 papers on sleep and circadian rhythms and is frequently invited to speak at national and international scientific conferences.

Professor David Lewis MB, BCh MSc MD – Professor of Clinical Vaccinology

Professor Lewis qualified in medicine and surgery in Cardiff Wales and subsequently received a doctorate in HIV disease.  He has specialised in infectious diseases and tropical medicine and up until recently he was Professor of Clinical Vaccinology and Medicine at St George’s Hospital, University of London.

Professor Lewis holds an advisory position with the Health and Safety Executive and European Medicines Agency advising on genetic modification, gene therapy and clinical trials with genetically modified molecules.

He has been Principal Investigator or Chief Investigator of numerous parenteral and mucosal vaccine trials, including first-use in humans of GM live attenuated mucosal vaccines.

He developed the St George’s Vaccine Institute from scratch as an international centre of excellence in translational medicine and vaccine trials, specialising in mucosal immunology, mucosal vaccine delivery, and live genetically modified mucosal vaccines. Until recently, Professor Lewis worked as the Deputy Director of the St George’s Vaccine Institute and the lead for adult research.  

Professor Lewis is coordinator of clinical trials for EU and Gates international consortia, with responsibilities including commissioning and overseeing GMP manufacture, release, QA/QC, and compilation of IMPD and regulatory dossiers; design, commissioning and reporting toxicology studies; trial project management and interaction with regulatory authorities.

He has published more than 50 research papers on clinical vaccinology and is frequently invited to speak at national and international scientific conferences.

Professor Hardev Pandha MB ChB PhD MRCP(UK) FRACP CSST FRCP – Professor of Oncology

Professor Pandha qualified in medicine and surgery from the University of Birmingham Medical School in 1986 and subsequently received a doctorate in 1996 from Imperial College School of Medicine.  He has been working as the Professor of Urological Oncology at the University of Surrey since 2006 and also holds an appointment as a Consultant Medical Oncologist at the Royal Surrey County Hospital. His key therapeutic specialities are in the areas of gene and viral therapy, cancer vaccines, urological malignancies and malignant melanoma. He has been Principal Investigator or Chief Investigator of a number of oncology trials.

Prior to this he worked at St George’s Hospital Medical School in London where he specialised in Tumour Immunology. During his career he has spent time conducting research at the Royal Marsden, Stanford University in the USA and the Imperial Cancer Research Fund.

Dr Mazhar Ajaz  PHD MRCP FRCR – Phase 1 Oncologist

Dr Ajaz qualified in medicine and surgery from the University of Southampton in 1996 and received a Doctorate in 2011 from the CRUK Centre for Cancer Therapeutics for his work which included the synthesis of a novel anti-cancer biologic and characterisation of in vitro and in vivo efficacy. He has recently started working at the University of Surrey as Clinical Senior Lecturer in Oncology & Cell Biology.  He has particular expertise and interest in neurooncology, the development of novel oncolytic  virotherapy strategies and therapeutic optimisation, and experimental and translational oncology.